Song Kenneth's most recent trade in RayzeBio Inc. was a trade of 1,622,968 Common Stock done at an average price of $62.5 . Disclosure was reported to the exchange on Feb. 26, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
RayzeBio Inc. | Song Kenneth | Director, PRESIDENT AND CHIEF EXECUTIVE | Sale or transfer of securities back to the company at price $ 62.50 per share. | 26 Feb 2024 | 1,622,968 | 0 | - | 62.5 | 101,435,500 | Common Stock |
RayzeBio Inc. | Kenneth Song | Director, PRESIDENT AND CHIEF EXECUTIVE | Sale or transfer of securities back to the company at price $ 0.00 per share. | 26 Feb 2024 | 758,607 | 0 | - | - | Employee Stock Option (right to buy) | |
RayzeBio Inc. | Song Kenneth | Director, PRESIDENT AND CHIEF EXECUTIVE | Sale or transfer of securities back to the company at price $ 0.00 per share. | 26 Feb 2024 | 480,000 | 0 | - | - | Employee Stock Option (right to buy) | |
RayzeBio Inc. | Song Kenneth | Director, PRESIDENT AND CHIEF EXECUTIVE | Sale or transfer of securities back to the company at price $ 0.00 per share. | 26 Feb 2024 | 114,763 | 0 | - | - | Employee Stock Option (right to buy) |